| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Anatomy and Neuroscience, 2Division of Neurosurgery in Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555-1069
Submitted 12 February 2004; accepted in final form 21 May 2004
 |
ABSTRACT |
|---|
|
and A
) and unmyelinated (C) afferent fibers. After capsaicin was injected intradermally into the plantar foot, a significant enhancement of DRRs was seen in C- and A-fibers but not in A-fibers. This enhancement of DRRs evoked by capsaicin injection was almost completely prevented by sympathectomy. However, if peripheral 
1-adrenoceptors were activated by intra-arterial injection of phenylephrine, the enhancement of DRRs evoked by capsaicin could be restored, whereas no such restoration was seen following pretreatment with an 2-adrenoceptor agonist, UK14,304. Under sympathetically intact conditions, the enhanced DRRs following capsaicin injection could be blocked by administration of terazosin, an 1-adrenoceptor antagonist, but not by administration of yohimbine, an 2-adrenoceptor antagonist. These results provide further evidence that the DRR-mediated neurogenic inflammation depends in part on intact sympathetic efferents acting on peripheral 1-adrenoceptors, which augment the sensitization of primary afferent nociceptors induced by capsaicin injection, helping trigger DRRs that produce vasodilation. |
|
INTRODUCTION |
|---|
|
; Brain and Williams 1985; Ferrell and Russell 1986; Kress et al. 1999; Lam and Ferrell 1989, 1991; Levine and Reichling 1999). The consequences are the development of vasodilation (redness, warmth), swelling, and pain. The component of inflammation that depends on release of substances from the terminals of primary afferent fibers is referred to as neurogenic inflammation (Stricker 1876; Szolcsányi 1996). The primary afferents that contribute to neurogenic inflammation are C- and A-nociceptors (Jänig and Lisney 1989; Low and Westerman 1989) that respond to capsaicin (CAP) (Szolcsányi 1996) and therefore contain transient receptor potential vanilloid-1 (TRPV1) receptors (Caterina and Julius 2001). These afferents are peptidergic and release tachykinins, such as substance P (SP), and calcitonin gene-related peptide (CGRP) (Holzer 1988).
Electrophysiological studies have suggested that much of the acute cutaneous neurogenic inflammation that follows intradermal injection of CAP is induced by the centrally mediated triggering of dorsal root reflexes (DRRs) carried by C- and A-afferent fibers (Lin et al. 2000a). DRRs can be evoked when inflammation is induced in either the skin or in a joint, and they have been shown to contribute to the development of neurogenic inflammation (Lin et al. 1999; Rees et al. 1995; Willis 1999).
On the other hand, evidence also suggests that the sympathetic postganglionic efferent terminals may be involved in the mediation of the peripheral inflammatory responses by interaction with primary afferent terminals (Jänig et al. 1996; Michaelis 2000). However, the mechanisms by which sympathetic nerves affect the development of neurogenic inflammation still remain obscure. Based on our studies showing that the spread of cutaneous vasodilation (flare) evoked by intradermal injection of CAP is reduced by sympathectomy (Lin et al. 2003), we propose the hypothesis that neurogenic inflammation resulting from the generation of DRRs may depend in part on a sympathetic–sensory interaction in the periphery. In this study, we have further examined electrophysiologically if the generation of DRRs, which has been shown to play an important role in development of neurogenic inflammation when there is tissue injury, is influenced by the presence of sympathetic efferents and have analyzed the possible adrenergic receptor subtypes on which sympathetic efferents exert their action in the periphery. Abstracts reporting some of this work have been published (Lin et al. 2000b, c).
|
|
METHODS |
|---|
|
Animal preparation
Animals were initially anesthetized with sodium pentobarbital (50 mg/kg, ip) to perform surgery. The external jugular vein was cannulated, and anesthesia was maintained by continuous infusion of sodium pentobarbital (5–8 mg/kg/h). Once a stable level of anesthesia was reached, the animals were paralyzed with pancuronium (0.3 
0.4 mg/h iv) and ventilated artificially. End-tidal CO2 was kept at 3.5 4.5%. Rectal temperature was monitored using a rectal probe and maintained at 37°C by a servo-controlled heating blanket.
DRR recordings
Laminectomy was carried out from T12 to S1 to expose the lumbosacral spinal cord. The dorsal roots and spinal cord were protected from drying and cooling by formation of a mineral oil pool between skin flaps and by circulating heated water through a metal tube placed in the pool. Dorsal roots L4, L5, and L6 were exposed. A rootlet of the L4 L5, or L6 dorsal root was cut distally, and the central end was carefully split into small filaments containing a single active fiber on a mirror plate. Evoked DRRs conveyed by a single fiber of the cut central end of the dorsal rootlet were recorded by placing one of the filaments on a silver unipolar hook electrode. DRRs were amplified and observed on analogue and digital storage oscilloscopes and discriminated from noise using a window discriminator. Digitized signals were processed by an interface (CED 1401) connected to a Pentium PC to construct peristimulus rate histograms for counting the firing rates. Spike-2 wavemark software was used to capture the original spikes after subtracting the noise level. DRRs were evoked by applying a series of calibrated von Frey filaments that had graded bending forces to an area on the foot. The sites from which DRRs could be evoked were considered the "receptive fields" for the DRRs. Because the threshold for evoking DRRs by mechanically stimulating peripheral afferent terminals varied with each experiment, an appropriate set of von Frey filaments was chosen for each animal. Care was taken to assure that the same unit was being recorded throughout the experiment by monitoring the size and shape of action potential using the digital oscilloscope.
The fiber types that conveyed DRRs were identified by conduction velocity as A-, A-, or C-fibers. Conduction velocity was measured with either of the following techniques.
1) Extracellular recordings of DRRs were made using two silver unipolar hook electrodes placed on two sites of the central stump of the same cut dorsal root filament with a fixed distance between the recording electrodes. DRRs were evoked by applying von Frey filaments to the "receptive field" on the foot. Conduction velocity was calculated by dividing the conduction distance between two electrodes (2.0 ± 0.5 mm) by conduction delays of the evoked action potential recorded at two locations on the same dorsal root filament.
2) The recordings were also done using one silver unipolar hook electrode placed on the cut dorsal rootlet filament. A bipolar stimulating electrode was placed on the cut dorsal rootlet 15–25 mm proximal to the recording site. Action potentials evoked by electrical stimulation were recorded with a fixed latency. The conduction velocity was calculated by dividing the conduction distance by the latency of the action potential. The shape and size of action potentials evoked by electrical stimulation were always monitored to assure that they were the same unit as ones evoked by mechanical stimulation using von Frey filaments.
Lumbar sympathectomy
Surgical sympathectomy at the L2–L6 level was done in the way described by Kim et al. (1993) and previously by our group (Lin et al. 2003; Zou et al. 2002). Briefly, the sympathetic chain was identified through a transperitoneal approach. All ganglia and the chains at L2–L6 were resected bilaterally. Animals were allowed to recover from surgery for 
1 wk before experiments were performed. At the termination of the experiment, the success of the sympathectomy was confirmed by the absence of noradrenergic axons on the femoral arteries on both sides in preparations stained with the fluorescent glyoxylic acid method (see Lin et al. 2003; Zou et al. 2002). The artery taken from the sham-operated animals has an extensive meshwork of noradrenergic axons, but in the artery in the sympathectomized rats, such axons were not seen at all (see Zou et al. 2002).
Peripheral administration of -adrenergic receptor agonists and antagonists
One branch of the femoral artery on the side of nerve recording was carefully isolated from connective tissue and ligated proximally. The artery was cannulated distally by a small-sized polyethylene tubing that was connected with a Hamilton syringe. The 1-adrenoceptor agonist, phenylephrine (0.05 µg, Tocris), (Lin et al. 2003) or the 2-adrenoceptor agonist, UK14,304 (0.3 µg, Tocris) (Lin et al. 2003), was administered intra-arterially 10 min prior to CAP injection in sympathectomized rats. The 1-adrenoceptor antagonist, terazosin (10 µg, Sigma) (Kyncl 1986), or the 2-adrenoceptor antagonist, yohimbine (15 µg, Sigma) (Howe et al. 1983), was administered locally by injection of the solution into the artery 10 min prior to CAP injection in sympathetically intact rats. Drugs were dissolved in saline and given in a volume of 10 µl for intra-arterial injection. For control purposes, the same volume of saline was given in other rats. Results from our experiments using blood flow measurements (Lin et al. 2003) indicate that the volume (10 µl) and concentrations of drug solution injected locally would not be enough to produce a systemic effect by spreading into the general circulation.
Experimental protocol
CAP was dissolved in Tween 80 (7%) and saline (93%) to a concentration of 1%. A volume of 10 µl was injected intradermally into the skin of the foot to evoke DRRs. DRRs from C-, A-, and A-fibers were recorded in groups of sympathetically intact and sympathectomized rats before and after intradermal injection of CAP. DRRs from sham-sympathectomized rats were also recorded before and after intradermal injection of CAP as a control for the surgical procedure.
To examine further if norepinephrine (NE) released from sympathetic efferents affected the CAP-induced enhancement of DRRs by modulating the sensitivity of primary afferent nociceptors and to determine what types of peripheral adrenergic receptor subtypes were involved, the following pharmacological manipulations were performed.
1) Observations were made on the effects of activation of peripheral -adrenoceptors on the CAP-induced enhanced DRRs under sympathectomized conditions. The 1- or 2-adrenoceptor agonists, phenylephrine or UK14,304, were administered intra-arterially in a volume of 10 µl 10 min prior to CAP injection. DRRs were tested for the effects of CAP injection. Saline, the vehicle used for dissolving the drugs, was also injected prior to CAP injection for control purposes.
2) Intra-arterial injection of terazosin or yohimbine was done under sympathetically intact conditions to examine if blockade of 1- or 2-adrenoceptors could affect the CAP-evoked DRRs. In one group of sympathetically intact rats, terazosin or yohimbine was injected intra-arterially 10 min before CAP was injected intradermally. DRRs were recorded before and after CAP injection. As a control, DRRs in a group in which saline was injected intra-arterially prior to CAP injection were also recorded before and after CAP injection.
Data analysis
A CED 1401Plus (a multi-channel data acquisition system by Cambridge Electronic Design Limited) with Spike-2 software was used for data recording and analysis on- or off-line. All data are presented as means ± SE. For single-fiber DRR recordings, responses to mechanical stimuli applied to the receptive field for 10 s were calculated by subtracting 10 s of background activity to yield a net increase in discharge rate. Discharge frequencies were compared before and after intradermal injection of CAP. Changes are expressed as a percentage of control values (100%). Statistical comparisons were performed with paired t-test. A grouped t-test was used to compare the difference in responses between groups having different treatments. P < 0.05 was taken as significant.
|
|
RESULTS |
|---|
|
-fibers under sympathetically intact and sympathectomized conditions
Our first series of experiments was designed to examine if sympathectomy would affect the CAP-evoked enhancement of DRRs. Consistent with our previous reports (Lin et al. 2000a), DRRs evoked by applying a graded series of von Frey hairs and recorded from single C- and A- (but not A-) afferent fibers of cut dorsal root filaments were significantly increased following intrademal injection of CAP under either sympathetically intact or sympathetically sham-operated (n = 4) conditions. Figures 1A and 2A show the examples of the enhanced DRRs recorded from an C -and A-fiber identified by conduction velocity in sympathetically intact rats. The enhancement reached its peak at around 30 min after CAP injection and lasted 60 min. A continuous observation was made until 90 min after CAP injection in three fibers (2 A- and 1 C-), and the enhanced responses were seen to recover at 70–90 min after CAP injection (data not shown), which was consistent with our previous observations (Lin et al. 1999). After sympathetic postganglionic efferents were removed surgically, CAP injection no longer enhanced DRRs (Figs. 1B and 2B). Under sympathetically intact conditions, the normalized peak values after CAP injection were 243.32 ± 138.52% (control values 100%) in C-fibers (n = 8) and 196.39 ± 72.28% in A-fibers (n = 9) compared with the values before CAP injection, respectively. After sympathectomy, peak values after CAP injection were 122.75 ± 18.5% in C-fibers (n = 6) and 116.65 ± 13.61% in A-fibers (n = 7). The differences between the groups were significant (P < 0.05; Fig. 3). However, there were no differences in the DRRs (P > 0.05) conveyed by A-fibers after CAP injection either in sympathetically intact (125.3 ± 19.6%, n = 5) or in sympathectomized (99.0 ± 12.0%, n = 5) rats (data not shown).
|
|
|
-adrenergic receptor agonists on evoked DRRs recorded from C- and A-fibers under sympathectomized conditions
Under sympathectomized conditions, peripheral 1- or 2-adrenoceptors were activated by intra-arterial injection of phenylephrine or UK14,304 10 min prior to intradermal CAP injection to see if activation of -adrenoceptors could mimic the conditions when the sympathetic efferents were present. As shown in Fig. 4, there were no obvious changes in DRRs after drug injection. However, the increases in the DRRs evoked by CAP were restored after the periphery was pretreated with phenylephrine by intra-arterial injection. The peak increases with phenylephrine pretreatment were 193.5 ± 45.8% (control values 100%; P < 0.05, n = 6) in C-fibers and 153.8 ± 41.8% (P < 0.05, n = 7) in A-fibers compared with the DRR response seen with intra-arterial injection of saline, when the grouped responses were 125.48 ± 18.5% in C-fibers (n = 6) and 116.65 ± 13.61% in A-fibers (n = 7). In contrast, pretreatment with UK14,304, an 2-adrenoceptor agonist, by intra-arterial injection did not significantly change the DRR responses induced by CAP injection. The peak increases with UK14,304 were 142.67 ± 23.34% in C-fibers (n = 6) and 140.69 ± 15.29% in A-fibers (n = 6), which were comparable with the DRR responses seen with intra-arterial injection of saline (P > 0.05; Fig. 5; Table 1).
|
|
|
-adrenoceptors on evoked DRRs recorded from C- and A-fibers after capsaicin injection under sympathetically intact conditions
In sympathetically intact rats, we further examined if the blockade of 1- or 2-adrenoceptors affected the CAP-evoked enhancement of DRRs. The antagonist was injected intra-arterially 10 min prior to CAP injection, and there was no obvious change in DRRs after drug injection. However, the enhancement of DRRs that took place after CAP injection was completely prevented after 1-adrenoceptors were blocked by intra-arterial injection of terazosin (Fig. 6). The peak values were 91.88 ± 20.09% in C-fibers (control values 100%) and 103.6 ± 23.91% in A-fibers, which was significantly lower than the responses in animals pretreated with saline (206.77 ± 69.61% in C-fibers, P < 0.01 and 186.66 ± 98.94% in A-fibers, P < 0.05). In contrast, blockade of 2-adrenoceptors by intra-arterial injection of yohimbine did not significantly affect the enhanced DRRs induced by CAP injection. The peak increases with yohimbine were 162.82 ± 22.83% in C-fibers and 151.77 ± 21.36% in A-fibers compared with the DRRs seen with intra-arterial injection of saline (P > 0.05; Fig. 7; Table 2).
|
|
|
|
|
DISCUSSION |
|---|
|
, 2000a) have provided direct evidence that enhanced DRRs after acute cutaneous inflammation induced by CAP injection are seen in both small myelinated and unmyelinated afferent nociceptors. These results, combined with data obtained by other laboratories showing that inflammatory peptides are released from the peripheral terminals of fine primary afferent nociceptors when they are antidromically stimulated (Holzer 1988; Kress et al. 1999), strongly support the view that DRRs are involved in neurogenic inflammation. This study, using the same acute cutaneous neurogenic inflammatory model, has further found that DRRs enhanced by CAP injection are subject to sympathetic modulation. DRRs are significantly reduced after sympathectomy. In sympathetically intact rats, blockade of peripheral 1-adrenoceptors with terazosin profoundly reduced the enhanced DRRs induced by CAP injection. On the other hand, when sympathectomized rats were pretreated with an 1-adrenoceptor agonist (phenylephrine) by intra-arterial injection, the reduction in the CAP-enhanced DRRs after sympathectomy could be restored. These findings suggest that sympathetic efferents may participate in modulation of the sensitivity of primary afferent nociceptors in the periphery, which in turn affects the sizes of the afferent volleys evoked by the mechanical stimuli that trigger the DRRs.
Antidromic activity in primary afferent terminals is a major mechanism by which inflammatory peptides are released to produce neurogenic inflammation. This process has been shown to be mediated centrally and can be initiated by intradermal injection of CAP or by induction of experimental arthritis (Lin et al. 1999; Rees et al. 1994; Sluka et al. 1993, 1995). The enhanced afferent discharge activates GABAergic interneurons in the spinal dorsal horn by release of glutamate onto non-NMDA and NMDA receptors (Zou et al. 2001). An increased release of GABA from GABAergic interneurons of the dorsal horn can result in an excessive primary afferent depolarization, which triggers DRRs (Willis 1999; Willis and Coggeshall 2004). CAP sensitivity is considered to be a principal pharmacological trait of a major subpopulation of sensory neurons. CAP-sensitive nociceptors are found mostly among unmyelinated primary afferent fibers (Jancso et al. 1977; Szolcsanyi 1977), but some are small myelinated primary afferent A-fibers (Michael and Priestley 1999; Nagy et al. 1983). Many of these fibers are peptidergic. There was no significant increase in DRRs recorded from A fibers after intradermal CAP injection in these experiments. Therefore it is strongly suggested that DRRs conveyed by C-and/or A-afferent fibers contribute to the induction of neurogenic inflammation. This result confirms our previous studies (Lin et al. 1999, 2000a).
Postganglionic sympathetic denervation either by surgical or chemical sympathectomy has been suggested experimentally and clinically to be an effective way of reducing pain behaviors in some neuropathic and inflammatory pain models without obviously affecting the functions of other systems (Green et al. 1993; Kim and Chung 1991; Kinnman and Levine 1995; Kinnman et al. 1997; Levine et al. 1986; Moon et al. 1999; Neil et al. 1991; Xie et al. 1995a). For instance, this experimental manipulation has been successfully used in a series of behavioral experiments by Chung's group in showing the pathophysiological mechanisms by which the sympathetic efferent outflow modulates neuropathic pain (Choi et al. 1994; Kim and Chung 1991; Moon et al. 1999; Xie et al. 2001). Experiments in anesthetized animals done by our group (Lin et al. 2003) have shown that sympathectomy by surgery done at 7–10 days before experiments does not significantly affect the resting blood flow level. Therefore, data both from awake and anesthetized animals do not indicate the possibility that sympathectomy would obviously affect physiological functions, which might interfere with our studies.
Our recent studies suggest that the generation and development of cutaneous neurogenic inflammation (flare) induced by CAP injection depends on intact postganglionic sympathetic efferents. Release of NE and/or neuropeptide Y (NPY) from sympathetic efferents activates 1-adrenergic and/or NPY Y2 receptors, which are believed to be located on the primary afferent terminals (Lin et al. 2003, 2004). Since CAP-induced flare in rats is mediated mainly by DRRs, these experiments further examined if the enhancement of DRRs induced by CAP injection is also sympathetically dependent. We found that either sympathectomy or blockade of peripheral 1-adrenoceptors with terazosin in sympathetically intact rats reduced dramatically the DRRs induced by CAP injection, suggesting that there is an endogenous release of NE from postganglionic sympathetic efferent terminals when tissue injury and NE release might enhance the sensitivity of primary afferent nociceptors to facilitate the process of induction of DRRs. These results are consistent with the data on neurogenic flare induced by CAP injection (Lin et al. 2003). It has been shown that sympathetic efferent activity can enhance ongoing impulse discharges in injured afferents that were previously silent following tissue injury (Shinder 1999). NE and sympathetic stimulation can enhance the activity of primary afferent C-fiber nociceptors innervating inflamed skin (Sato and Kumazawa 1996; Sato and Perl 1991). Cutaneous C-fiber nociceptors in rats that were sensitized by the injection of a mixture of inflammatory mediators into the receptive field responded to sympathetic stimulation and local arterial injection of NE (Hu and Zhu 1989). In an acute cutaneous inflammatory model induced by intradermal injection of CAP, both exogenous and endogenous NE release in the skin produced a prolonged decrease in heat pain threshold at the site where NE was released (Drummond 1995, 1998). Thus activity in sympathetic fibers would help enhance the activity in sensitized nociceptors, which is the key to initiating the induction and development of DRRs. Sympathetic influence on different arthritic models has been shown to be inconsistent. Sluka et al. (1994) reported that sympathetic denervation did not obviously affect the arthritis induced by knee joint injection of kaolin and carrageenan. A series of studies by Green's group showed that arthritis induced by bradykinin injection into the cavity of knee joint, which was characterized by plasma extravasation, was sympathetically dependent (Green et al. 1993). Also, they found that a neuroendocrine pathway could be activated after bradykinin-induced plasma extravasation developed (Green et al. 1995; Miao et al. 1996). This negative feedback mechanism was also sympathetically dependent and initiated by stimulation of primary afferent C-fibers (Green et al. 1995, 1997). Thus it seems that this sympathetically dependent pathway is actually a self-protection mechanism to prevent tissue from being further inflamed. However, we have not tried to study if such a mechanism also applies to the CAP-induced inflammation.
Another of our findings was that the reduction in the CAP-induced enhancement of DRRs following sympathetic denervation could be rekindled by local activation of 1-, but not 2-, adrenoceptors. Based on this observation, we assume that 1-receptors that are presumably located on the primary afferent fibers are activated by phenylephrine. This process mimics the conditions in sympathetically intact animals, in which NE is released from the sympathetic efferent terminals. The results of the experiment using intra-arterial injection of an 1 receptor antagonist under sympathetically intact conditions were consistent with those after injection of an 1 receptor agonist, implying that the CAP-evoked sensitization of primary afferent nociceptors is normally dependent on the presence of postganglionic sympathetic efferents that would release NE to modulate nociceptive transmission by acting on 1 receptors. This peripheral modulatory mechanism may indirectly influence the induction of DRRs that participate in the pathogenesis of neurogenic inflammation. So far, a variety of observations about the subtype of -adrenergic receptors involved in sympathetic modulation of pathological pain transmission have been reported in clinical studies and also in experimental studies, mostly on neuropathic pain models. In contrast, our previous and present studies have been done in the CAP-induced neurogenic inflammatory pain model. Hyperalgesia induced by intradermal CAP injection is mediated by 1-adrenergic receptors (Kinnman and Levine 1995). Lee et al. (1999) showed that the subtype of -adrenergic receptor mediating the neuropathy induced mechanical allodynia and ectopic discharges of dorsal root ganglion cells is the 1-adrenergic, not the 2-adrenergic, receptor. Their group has also shown an increased expression of the 1b-adrenergic receptor subtype in a neuropathic pain model (Xie et al. 2001). In addition, some other data suggest that 2 or both 1 and 2 receptors are involved in various types of neuropathic pain models (Chen et al. 1996; Hord et al. 2001; Sato and Perl 1991; Xie et al. 1995b). One possible explanation could be that different -adrenergic receptor subtypes might participate in mediation of different types of neuropathic pain. Combined with our recent studies with CAP-evoked neurogenic flare (Lin et al. 2003, 2004), our data support the hypothesis that the induction and development of neurogenic inflammation in rats are mediated mainly by DRRs, which are modulated by postganglionic sympathetic efferents in the periphery by an action on 1-adrenoceptors.
In conclusion, DRRs conducted by C-and A-primary afferent fibers following CAP play a major role in the induction and development of neurogenic inflammation, which are suggested to be sympathetically dependent. This sensory–sympathetic interaction seems to be mediated by an 1-adrenergic mechanism in the periphery. The sympathetic postganglionic terminals are essential for nociceptive signal transmission under pathological conditions, such as tissue injury. A positive feedback loop mediated by a dorsal horn circuit is activated following CAP injection to trigger DRRs, which helps induce and develop neurogenic inflammation.
|
|
GRANTS |
|---|
|
|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: Q. Lin, Dept. of Anatomy and Neuroscience, The Univ. of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1069 (E-mail: qilin{at}utmb.edu).
|
|
REFERENCES |
|---|
|
Brain SD and Williams TJ. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 86: 855–860, 1985.[Web of Science][Medline]
Caterina MJ and Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Ann Rev Neurosci 24: 487–517, 2001.[CrossRef][Web of Science][Medline]
Chen Y, Michaelis M, Jianig W, and Devor M. Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons. J Neurophysiol 76: 3721–3730, 1996.
Choi Y, Yoon YW, Na HS, Kim SH, and Chung JM. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59: 369–376, 1994.[CrossRef][Web of Science][Medline]
Drummond PD. Noradrenaline increases hyperalgesia to heat in skin sensitized by capsaicin. Pain 60: 311–315, 1995.[CrossRef][Web of Science][Medline]
Drummond PD. The effect of noradrenaline, angiotensin II and vasopressin on blood flow and sensitivity to heat in capsaicin-treated skin. Clin Auton Res 8: 87–93, 1998.[CrossRef][Web of Science][Medline]
Ferrell WR and Russell NJ. Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetized cat. J Physiol 379: 407–416, 1986.
Green PG, Jänig W, and Levine JD. Negative feedback neuroendocrine control of the inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci 17: 3234–3238, 1997.
Green PG, Luo J, Heller PH, and Levine JD. Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience 55 :1037–1043, 1993.[CrossRef][Web of Science][Medline]
Green PG, Miao FJP, Jänig W, and Levine JD. Negative feedback neuroendocrine control of the inflammatory response in rats. J Neurosci 15: 4678–4686, 1995.[Abstract]
Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24: 739–768, 1988.[CrossRef][Web of Science][Medline]
Hord AH, Chalfoun AG, Denson DD, and Azevedo MI. Systemic tizanidine hydrochloride (Zanaflex) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Anesth Analg 93: 1310–1315, 2001.
Howe JR, Wang JY, and Yaksh TL. Selective antagonism of the antinociceptive effect of intrathecally applied adrenergic agonists by intrathecal prazosin and intrathecal yohimbine. J Pharmacol Exp Ther 224: 552–558, 1983.
Hu S and Zhu J. Sympathetic facilitation of sustained discharges of polymodal nociceptors. Pain 38: 85–90, 1989.[CrossRef][Web of Science][Medline]
Jancso G, Kiraly E, and Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature 270: 741–743, 1977.[CrossRef][Medline]
Jänig W and Lisney SJW. Small diameter myelinated afferents produce vasodilatation but not plasma extravasation in rat skin. J Physiol 415: 477–486, 1989.
Jänig W, Levine JD, and Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. In: Progress in Brain Research, edited by Kumazawa L, Kruger L, and Mizumura K. Amsterdam: Elsvier, 1996, p. 161–184.
Kim SH and Chung JM. Sympathectomy alleviates mechanical allodynia in an experimental animal model for neuropathy in the rat. Neurosci Lett 134: 131–134, 1991.[CrossRef][Web of Science][Medline]
Kim SH, Na HS, Sheen K, and Chung JM. Effects of sympathectomy on a rat model of peripheral neurophathy. Pain 55: 85–92, 1993.[CrossRef][Web of Science][Medline]
Kinnmann E and Levine JD. Sensory and sympathetic contributions to nerve injury-induced sensory abnormalities in the rat. Neuroscience 64: 751–767, 1995.[CrossRef][Web of Science][Medline]
Kinnmann E, Nygards EB, and Hansson P. Peripheral -adrenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain 69: 79–85, 1997.[CrossRef][Web of Science][Medline]
Kress M, Guthmann C, Averbeck B, and Reeh PW. Calcitonin gene-related peptide and prostaglandin E2 but not substance P release induced by antidromic nerve stimulation from rat skin in vitro. Neuroscience 89: 303–310, 1999.[CrossRef][Web of Science][Medline]
Kyncl JJ. Pharmacology of terazosin. Am J Med 80: 12–19, 1986.[Web of Science][Medline]
Lam FY and Ferrell WR. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis 48: 928–932, 1989.
Lam FY and Ferrell WR. Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br J Pharmacol 103: 1263–1267, 1991.[Web of Science]
Lee DH, Liu X, Kim HT, Chung K, and Chung JM. Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats. J Neurophysiol 81: 2226–2233, 1999.
Levine JD and Reichling DB. Peripheral mechanisms of inflammatory pain. In: Textbook of Pain, (4th ed.), edited by Wall PD and Melzack R. Edinburgh, Churchill Livingstone, 1999, p. 59–84.
Levine JD, Dardick SJ, Roizen MF, Helms C, and Basbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 12: 3423–3429, 1986.
Lin Q, Wu J, and Willis WD. Dorsal root reflexes and cutaneous neurogenic inflammation after intrademal injection of capsaicin in rats. J Neurophysiol 82: 2602–2611, 1999.
Lin Q, Zou XJ, Fang L, and Willis WD. Sympathetic modulation of acute cutaneous flare induced by intradermal injection of capsaicin in anesthetized rats. J Neurophysiol 89: 853–861, 2003.
Lin Q, Zou XJ, Ren Y, Wang J, Fang L, and Willis WD. Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience 123: 337–347, 2004.[CrossRef][Web of Science][Medline]
Lin Q, Zou XJ, and Willis WD. A and C primary afferents convey dorsal root reflexes after intrademal injection of capsaicin in rats. J Neurophysiol 84: 2695–2698, 2000a.
Lin Q, Zou XJ, and Willis WD. Dorsal root reflexes occur following intradermal injection of capsaicin and the effects of sympathectomy. Chin J Pain Med 6(Suppl): 16, 2000b.
Lin Q, Zou XJ, and Willis WD. Sympathetic modulation of dorsal root reflexes evoked by intradermal injection of capsaicin. Soc Neurosci Abstr 26: 948, 2000c.
Low A and Westerman RA. Neurogenic vasodilation in the rat hairy skin measured using a laser Doppler flowmeter. Life Sci 45: 49–57, 1989.[CrossRef][Web of Science][Medline]
Miao FJ, Jänig W, Green PG, and Levine JD. Inhibition of bradykinin-induced synovial plasma extravasation produced by intrathecal nicotine is mediated by the hypothalamopituitary adrenal axis. J Neurophysiol 76: 2813–2821, 1996.
Michael GJ and Priestley JV. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci 19: 1844–1854, 1999.
Michaelis M. Coupling of sympathetic and somatosensory neurons following nerve injury: mechanisms and potential significance for the generation of pain. In: Proceedings of the 9th World Congress on Pain, edited by Devor M, Rowbotham MC, and Wiesenfeld-Hallin Z. Seattle, WA: IASP Press, 2000, p. 645–656.
Moon DE, Lee DH, Han HC, Xie JG, Coggeshall RE, and Chung JM. Adrenergic sensitivity of the sensory receptors modulating mechanical allodynia in a rat neuropathic pain model. Pain 80: 589–595, 1999.[CrossRef][Web of Science][Medline]
Nagy JI, Iversen LL, Goedert M, Chapman D, and Hunt SP. Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci 3: 399–406, 1983.[Abstract]
Neil A, Attal N, and Guibaud G. Effects of guanethidine on sensitization to natural stimuli and self-mutilating behaviour in a rat with a peripheral neuropathy. Brain Res 565: 237–246, 1991.[CrossRef][Web of Science][Medline]
Rees H, Sluka KA, Westlund KN, and Willis WD. Do dorsal root reflexes augment peripheral inflammation? Neuroreport 5: 821–824, 1994.[Web of Science][Medline]
Rees H, Sluka KA, Westlund KN, and Willis WD. The role of glutamate and GABA receptors in the generation of dorsal root reflexes by acute arthritis in the anaesthetized rat. J Physiol 484: 437–445, 1995.
Sato J and Kumazawa T. Sympathetic modulation of cutaneous polymodal receptors in chronically inflamed and diabetic rats. Prog Brain Res 113: 153–159, 1996.[Web of Science][Medline]
Sato J and Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 251: 1608–1610, 1991.
Shinder V, Govrin-Lippmann R, Cohen S, Belenky M, Ilin P, Fried K, Wilkinson HA, and Devor M. Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury. J Neurocytol 28: 743–761, 1999.[CrossRef][Web of Science][Medline]
Sluka KA, Lawand NB, and Westlund KN. Joint inflammation is reduced by dorsal rhizotomy and not by sympathectomy or spinal cord transaction. Ann Rheum Dis 53: 309–314, 1994.
Sluka KA, Rees H, and Willis WD. Fiber types contributing to dorsal root reflexes induced by joint inflammation in cats and monkeys. J Neurophysiol 74: 981–989, 1995.
Sluka KA, Willis WD, and Westlund KN. Joint inflammation and hyperalgesia are reduced by spinal bicuculine. Neuroreport 5: 109–112, 1993.[Web of Science][Medline]
Stricker S. Unterschungen über die Gefässwurzeln del Ischiadicus. Sitz Kaiserl Akad Wiss Wien 73: 173–185,1876.
Szolcsanyi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol 73: 251–259, 1977.
Szolcsányi J. Neurogenic inflammation: reevaluation of axon reflex theory. In: Neurogenic Inflammation, edited by Geppetti P and Holzer P. New York: CRC, 1996, p. 33–42.
Willis WD. Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res 124: 395–421, 1999.[CrossRef][Web of Science][Medline]
Willis WD and Coggeshall RE. Structure of the dorsal horn. In: Sensory Mechanisms of the Spinal Cord (3rd ed.). New York: Kluwer Academic/Plenum Publishers, 2004, p. 1–962.
Xie JG, Yoon YW, Yom SS, and Chung JM. Norepinephrine rekindles mechanical allodynia in sympathectomized neuropathic rat. Analgesia 1: 107–113, 1995a.
Xie JG, Lee HY, Wang C, Chung JM, and Chung K. Differential expression of alpha1-adrenoceptor subtype mRNAs in the dorsal root ganglion after spinal nerve ligation. Brain Res Mol Brain Res 93: 164–172, 2001.[Medline]
Xie Y, Zhang J, Petersen M, and LaMotte RH. Functional changes in dorsal root ganglion cells after chronic nerve constriction in the rat. J Neurophysiol 73: 1811–1820, 1995b.
Zou X, Lin Q, and Willis WD. NMDA and non-NMDA receptor antagonists attenuate increased Fos expression in spinal dorsal horn GABAergic neurons after intradermal injection of capsaicin in rats. Neuroscience 106: 171–182, 2001.[CrossRef][Web of Science][Medline]
Zou X, Lin Q, and Willis WD. The effects of sympathectomy on capsaicin-evoked Fos expression of spinal dorsal horn GABAergic neurons. Brain Res 958: 322–329, 2002.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
|
|
 |
|
  U. C. Kopp, M. Z. Cicha, L. A. Smith, J. Mulder, and T. Hokfelt Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of {alpha}1- and {alpha}2-adrenoceptors on renal sensory nerve fibers Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1561 - R1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ren, X. Zou, L. Fang, and Q. Lin Involvement of Peripheral Purinoceptors in Sympathetic Modulation of Capsaicin-Induced Sensitization of Primary Afferent Fibers J Neurophysiol, November 1, 2006; 96(5): 2207 - 2216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Valencia-de Ita, N. B. Lawand, Q. Lin, G. Castaneda-Hernandez, and W. D. Willis Role of the Na+-K+-2Cl- Cotransporter in the Development of Capsaicin-Induced Neurogenic Inflammation J Neurophysiol, June 1, 2006; 95(6): 3553 - 3561. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
TOP
ABSTRACT
INTRODUCTION
